<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
TEVA
Teva
$
()


  • Corcept Therapeutics weakness a buying opportunity, says Canaccord

    6/18/2024 - 08:26am
  • Teva sues Corcept over alleged mifepristone market monopoly, Reuters says

    6/13/2024 - 17:50pm
  • Teva call volume above normal and directionally bullish

    6/6/2024 - 10:45am
  • Teva price target raised by $1 at Barclays, here's why

    6/5/2024 - 05:27am
  • Teva presents first real-world data from IMPACT-TD Registry study

    6/2/2024 - 07:40am
  • Teva price target raised by $3 at BofA, here's why

    5/30/2024 - 06:48am
  • Teva says FDA approves AUSTEDO XR as one pill, once-daily

    5/29/2024 - 18:43pm
  • Teva, Alvotech announce Simlandi injection now available in U.S.

    5/20/2024 - 20:36pm
  • Teva price target raised by $1 at Piper Sandler, here's why

    5/13/2024 - 06:47am
  • Teva price target raised by $2 at BofA, here's why

    5/9/2024 - 09:38am
  • Teva price target raised by $3 at Barclays, here's why

    5/9/2024 - 05:30am
  • Fly Intel: Pre-market Movers

    5/8/2024 - 09:13am
  • Teva sees FY24 capital expenditures $500M

    5/8/2024 - 08:48am
  • Teva backs FY24 EPS view $2.20-$2.50, consensus $2.41

    5/8/2024 - 07:35am
  • Teva reports Q1 EPS 48c, consensus 51c

    5/8/2024 - 07:33am
dynamic_feed Breaking News